🟡 Medium ImpactCorporate
Elantas Beck India approves ₹560Cr plant expansion
Elantas Beck India approves ₹560Cr investment for capacity expansion at its Ankleshwar plant. The move aims to meet rising global demand and strengthen its position in the specialty chemicals segment. The capex is expected to enhance production scalability and export potential. The plant upgrade will be completed in phases over the next few years.
📊 STOCKS: ELANTAS | 🏢 SECTOR: Corporate | #MEDIUMIMPACT #Capex
#Capex#Manufacturing#Growth
Stocks mentioned
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →